Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients

Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease of pulmonary hypertension (PH) as a consequence obstructive of pulmonary arteries with thromboembolism. Augmented pulmonary vascular resistance and pulmonary artery pressure (PAP) can ultimately lead to the ri...

Full description

Bibliographic Details
Main Authors: Mustafa Oguz, Tarik Kivrak, Murat Sunbul, Fuad Dede, Bedrettin Yildizeli, Bulent Mutlu
Format: Article
Language:English
Published: Galenos Publishing House 2019-01-01
Series:International Journal of the Cardiovascular Academy
Subjects:
Online Access:http://www.ijcva.com/article.asp?issn=2405-8181;year=2019;volume=5;issue=4;spage=152;epage=158;aulast=Oguz
_version_ 1797707387808776192
author Mustafa Oguz
Tarik Kivrak
Murat Sunbul
Fuad Dede
Bedrettin Yildizeli
Bulent Mutlu
author_facet Mustafa Oguz
Tarik Kivrak
Murat Sunbul
Fuad Dede
Bedrettin Yildizeli
Bulent Mutlu
author_sort Mustafa Oguz
collection DOAJ
description Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease of pulmonary hypertension (PH) as a consequence obstructive of pulmonary arteries with thromboembolism. Augmented pulmonary vascular resistance and pulmonary artery pressure (PAP) can ultimately lead to the right ventricular dysfunction, which leads to adaptive and maladaptive changes. Right ventricle (RV) remodeling can cause clinical deterioration and RV failure. Aims and Objectives: We aimed to evaluate the RV functions with a new diagnostic modality 2-deoxy-2-(18F)-fluoro-D-glucose (FDG)-positron emission tomography (PET) in patients with CTEPH. Materials and Methods: We included 53 patients diagnosed with CTEPH who were planned to have pulmonary thromboendarterectomy (PEA) and did not have any contraindication for cardiac PET/computed tomography (CT). We performed transthoracic echo, cardiac PET/CT, 6-minute walk distance (6-MWT), and right heart catheterization 1 week before PEA surgery. Results: The patients divided into two groups according to RV/left ventricle (LV) FDG-PET uptake ratio, RV/LV ≤1, and RV/LV >1. Six-MWD was significantly higher in the RV/LV ≤1 group (P = 0.005). Pro-BNP was considerably higher in the RV/LV >1 group (P = 0.041). Conclusion: The present study aims to demonstrate the RV/LV FDG-PET uptake ratio could be used in the noninvasive diagnostic method in diagnosing, treatment strategy, and clinical follow-up in patients with CTEPH.
first_indexed 2024-03-12T06:05:39Z
format Article
id doaj.art-4ceed762d4f7498f8b203254b563678f
institution Directory Open Access Journal
issn 2405-8181
2405-819X
language English
last_indexed 2024-03-12T06:05:39Z
publishDate 2019-01-01
publisher Galenos Publishing House
record_format Article
series International Journal of the Cardiovascular Academy
spelling doaj.art-4ceed762d4f7498f8b203254b563678f2023-09-03T03:35:48ZengGalenos Publishing HouseInternational Journal of the Cardiovascular Academy2405-81812405-819X2019-01-015415215810.4103/IJCA.IJCA_35_19Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patientsMustafa OguzTarik KivrakMurat SunbulFuad DedeBedrettin YildizeliBulent MutluBackground: Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease of pulmonary hypertension (PH) as a consequence obstructive of pulmonary arteries with thromboembolism. Augmented pulmonary vascular resistance and pulmonary artery pressure (PAP) can ultimately lead to the right ventricular dysfunction, which leads to adaptive and maladaptive changes. Right ventricle (RV) remodeling can cause clinical deterioration and RV failure. Aims and Objectives: We aimed to evaluate the RV functions with a new diagnostic modality 2-deoxy-2-(18F)-fluoro-D-glucose (FDG)-positron emission tomography (PET) in patients with CTEPH. Materials and Methods: We included 53 patients diagnosed with CTEPH who were planned to have pulmonary thromboendarterectomy (PEA) and did not have any contraindication for cardiac PET/computed tomography (CT). We performed transthoracic echo, cardiac PET/CT, 6-minute walk distance (6-MWT), and right heart catheterization 1 week before PEA surgery. Results: The patients divided into two groups according to RV/left ventricle (LV) FDG-PET uptake ratio, RV/LV ≤1, and RV/LV >1. Six-MWD was significantly higher in the RV/LV ≤1 group (P = 0.005). Pro-BNP was considerably higher in the RV/LV >1 group (P = 0.041). Conclusion: The present study aims to demonstrate the RV/LV FDG-PET uptake ratio could be used in the noninvasive diagnostic method in diagnosing, treatment strategy, and clinical follow-up in patients with CTEPH.http://www.ijcva.com/article.asp?issn=2405-8181;year=2019;volume=5;issue=4;spage=152;epage=158;aulast=Oguzcardiac fluoro-d-glucose positron emission tomographychronic thromboembolic pulmonary hypertensionpulmonary vascular resistanceright ventricular remodeling
spellingShingle Mustafa Oguz
Tarik Kivrak
Murat Sunbul
Fuad Dede
Bedrettin Yildizeli
Bulent Mutlu
Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients
International Journal of the Cardiovascular Academy
cardiac fluoro-d-glucose positron emission tomography
chronic thromboembolic pulmonary hypertension
pulmonary vascular resistance
right ventricular remodeling
title Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients
title_full Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients
title_fullStr Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients
title_full_unstemmed Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients
title_short Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients
title_sort diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients
topic cardiac fluoro-d-glucose positron emission tomography
chronic thromboembolic pulmonary hypertension
pulmonary vascular resistance
right ventricular remodeling
url http://www.ijcva.com/article.asp?issn=2405-8181;year=2019;volume=5;issue=4;spage=152;epage=158;aulast=Oguz
work_keys_str_mv AT mustafaoguz diagnosticmodalityforevaluationofrightventricleinchronicthromboembolicpulmonaryhypertensionpatients
AT tarikkivrak diagnosticmodalityforevaluationofrightventricleinchronicthromboembolicpulmonaryhypertensionpatients
AT muratsunbul diagnosticmodalityforevaluationofrightventricleinchronicthromboembolicpulmonaryhypertensionpatients
AT fuaddede diagnosticmodalityforevaluationofrightventricleinchronicthromboembolicpulmonaryhypertensionpatients
AT bedrettinyildizeli diagnosticmodalityforevaluationofrightventricleinchronicthromboembolicpulmonaryhypertensionpatients
AT bulentmutlu diagnosticmodalityforevaluationofrightventricleinchronicthromboembolicpulmonaryhypertensionpatients